127 related articles for article (PubMed ID: 33208687)
1. Microcirculatory changes in the liver of patients with refractory ascites and their relationship with diabetes and alcohol.
Elkrief L; Buyse S; Panhard X; Baudry C; Gault N; Moreau R; Rautou PE; Belghiti J; Durand F; Bedossa P; Paradis V; Valla D
Eur J Gastroenterol Hepatol; 2021 Dec; 33(1S Suppl 1):e145-e152. PubMed ID: 33208687
[TBL] [Abstract][Full Text] [Related]
2. Impact of cardiac function, refractory ascites and beta blockers on the outcome of patients with cirrhosis listed for liver transplantation.
Giannelli V; Roux O; Laouénan C; Manchon P; Ausloos F; Bachelet D; Rautou PE; Weiss E; Moreau R; Mebazaa A; Cohen-Solal A; Durand F; Francoz C
J Hepatol; 2020 Mar; 72(3):463-471. PubMed ID: 31622697
[TBL] [Abstract][Full Text] [Related]
3. Survival Benefit of Tolvaptan for Refractory Ascites in Patients with Advanced Cirrhosis.
Tajiri K; Tokimitsu Y; Ito H; Atarashi Y; Kawai K; Minemura M; Yasumura S; Takahara T; Shimizu Y; Sugiyama T
Dig Dis; 2018; 36(4):314-321. PubMed ID: 29852495
[TBL] [Abstract][Full Text] [Related]
4. Transjugular intrahepatic portosystemic shunt and alfapump® system for refractory ascites in liver cirrhosis: Outcomes and complications.
Will V; Rodrigues SG; Stirnimann G; Gottardi A; Bosch J; Berzigotti A
United European Gastroenterol J; 2020 Oct; 8(8):961-969. PubMed ID: 32588789
[TBL] [Abstract][Full Text] [Related]
5. [The significance of urine sodium measurement after furosemide administration in diuretics-unresponsive patients with liver cirrhosis].
Cho HS; Park GT; Kim YH; Shim SG; Kim JB; Lee OY; Choi HS; Hahm JS; Lee MH
Taehan Kan Hakhoe Chi; 2003 Dec; 9(4):324-31. PubMed ID: 14695699
[TBL] [Abstract][Full Text] [Related]
6. Prognosis of surgical hernia repair in cirrhotic patients with refractory ascites.
Kim SW; Kim MA; Chang Y; Lee HY; Yoon JS; Lee YB; Cho EJ; Lee JH; Yu SJ; Yoon JH; Park KJ; Kim YJ
Hernia; 2020 Jun; 24(3):481-488. PubMed ID: 31512088
[TBL] [Abstract][Full Text] [Related]
7. ePTFE-TIPS vs repetitive LVP plus albumin for the treatment of refractory ascites in patients with cirrhosis.
Bucsics T; Hoffman S; Grünberger J; Schoder M; Matzek W; Stadlmann A; Mandorfer M; Schwabl P; Ferlitsch A; Peck-Radosavljevic M; Trauner M; Karner J; Karnel F; Reiberger T
Liver Int; 2018 Jun; 38(6):1036-1044. PubMed ID: 29091351
[TBL] [Abstract][Full Text] [Related]
8. Interactions between virus-related factors and post-transplant ascites in patients with hepatitis C and no cirrhosis: role of cryoglobulinemia.
Tripon S; Francoz C; Albuquerque A; Paradis V; Boudjema H; Voitot H; Belghiti J; Valla D; Durand F
Transpl Int; 2015 Feb; 28(2):162-9. PubMed ID: 25267442
[TBL] [Abstract][Full Text] [Related]
9. Albumin May Prevent the Morbidity of Paracentesis-Induced Circulatory Dysfunction in Cirrhosis and Refractory Ascites: A Pilot Study.
Tan HK; James PD; Wong F
Dig Dis Sci; 2016 Oct; 61(10):3084-3092. PubMed ID: 27048451
[TBL] [Abstract][Full Text] [Related]
10. Clinical characteristics and outcome of patients with cirrhosis and refractory ascites.
Moreau R; Delègue P; Pessione F; Hillaire S; Durand F; Lebrec D; Valla DC
Liver Int; 2004 Oct; 24(5):457-64. PubMed ID: 15482343
[TBL] [Abstract][Full Text] [Related]
11. Splanchnic hemodynamic factors in cirrhosis with refractory ascites.
Lebrec D; Kotelanski B; Cohn JN
J Lab Clin Med; 1979 Feb; 93(2):301-9. PubMed ID: 429841
[TBL] [Abstract][Full Text] [Related]
12. Association between the Serum Sodium Levels and the Response to Tolvaptan in Liver Cirrhosis Patients with Ascites and Hyponatremia.
Hayashi M; Abe K; Fujita M; Okai K; Takahashi A; Ohira H
Intern Med; 2018 Sep; 57(17):2451-2458. PubMed ID: 29607963
[TBL] [Abstract][Full Text] [Related]
13. Risk factors for hepatic encephalopathy in patients with cirrhosis and refractory ascites: relevance of serum sodium concentration.
Guevara M; Baccaro ME; Ríos J; Martín-Llahí M; Uriz J; Ruiz del Arbol L; Planas R; Monescillo A; Guarner C; Crespo J; Bañares R; Arroyo V; Ginès P
Liver Int; 2010 Sep; 30(8):1137-42. PubMed ID: 20602681
[TBL] [Abstract][Full Text] [Related]
14. Refractory Ascites in Liver Cirrhosis.
Adebayo D; Neong SF; Wong F
Am J Gastroenterol; 2019 Jan; 114(1):40-47. PubMed ID: 29973706
[TBL] [Abstract][Full Text] [Related]
15. Incidence and characteristics of type 2 hepatorenal syndrome in patients with cirrhosis and refractory ascites.
Sersté T; Lebrec D; Valla D; Moreau R
Acta Gastroenterol Belg; 2008; 71(1):9-14. PubMed ID: 18396743
[TBL] [Abstract][Full Text] [Related]
16. Propranolol use in patients with cirrhosis and refractory ascites: A nationwide study.
Chen YC; Li YD; Lu CM; Huang WC; Kao SS; Chen WC
Saudi J Gastroenterol; 2022; 28(2):108-114. PubMed ID: 35295067
[TBL] [Abstract][Full Text] [Related]
17. Renal duplex Doppler ultrasound in patients with HCV related liver cirrhosis.
Fouad YM; Mokarrab H; Elgebaly AF; El-Amin H; Abdel-Raheem EM; Sharawy MA; Shatat ME
Trop Gastroenterol; 2009; 30(4):213-8. PubMed ID: 20426281
[TBL] [Abstract][Full Text] [Related]
18. Long-term clinical outcome of patients with cirrhosis and refractory ascites treated with transjugular intrahepatic portosystemic shunt insertion.
Tan HK; James PD; Sniderman KW; Wong F
J Gastroenterol Hepatol; 2015 Feb; 30(2):389-95. PubMed ID: 25168607
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of hernia repair operation in Child-Turcotte-Pugh class C cirrhosis and refractory ascites.
Park JK; Lee SH; Yoon WJ; Lee JK; Park SC; Park BJ; Jung YJ; Kim BG; Yoon JH; Kim CY; Ha J; Park KJ; Kim YJ
J Gastroenterol Hepatol; 2007 Mar; 22(3):377-82. PubMed ID: 17295770
[TBL] [Abstract][Full Text] [Related]
20. Non-selective beta-blockers are not associated with increased mortality in cirrhotic patients with ascites.
Onali S; Kalafateli M; Majumdar A; Westbrook R; O'Beirne J; Leandro G; Patch D; Tsochatzis EA
Liver Int; 2017 Sep; 37(9):1334-1344. PubMed ID: 28296047
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
